Literature DB >> 31774951

Advancing Legislation on Drug Pricing - Is There a Path Forward?

Stacie B Dusetzina1, Jonathan Oberlander1.   

Abstract

Mesh：

Year:  2019        PMID： 31774951     DOI： 10.1056/NEJMp1914044

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Value and affordability of CAR T-cell therapy in the United States.

Authors:  Salvatore Fiorenza; David S Ritchie; Scott D Ramsey; Cameron J Turtle; Joshua A Roth
Journal:  Bone Marrow Transplant       Date:  2020-05-30       Impact factor: 5.483

2.  Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs.

Authors:  Daniel M Hartung; Kirbee A Johnston; Dennis N Bourdette; Randi Chen; Chien-Wen Tseng
Journal:  Neurol Clin Pract       Date:  2021-08

3.  Impact of a commercial accountable care organization on prescription drugs.

Authors:  Hui Zhang; David W Cowling; Joanne M Graham; Erik Taylor
Journal:  Health Serv Res       Date:  2021-01-28       Impact factor: 3.734

4.  Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.

Authors:  Benjamin N Rome; William B Feldman; Rishi J Desai; Aaron S Kesselheim
Journal:  JAMA Netw Open       Date:  2021-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.